maxgraft® granules

PROCESSED HUMAN ALLOGRAFT

natural bone regeneration

SHORTER TREATMENT TIMES

EARLIER REENTRY

maxgraft® granules are allograft bone substitute from human donor bone, processed by the Cells+Tissuebank Austria with a special cleaning process (Allotec® process) and available in cancellous and cortico-cancellous form. Due to its preserved natural bone structure and collagen content, it serves as a scaffold for natural bone regeneration and has the potential of complete remodeling into patients’ own bone 1,2.

FAST REGENERATION

The cancellous structure allows an optimal revascularization and supply of vital cells and therefore enables a rapid regeneration of vital bone tissue1. By adding a compact and dense bone ratio to the cancellous granules (maxgraft® cortico-cancellous granules) a greater volume stability is given, which is useful in cases of for example off-contour augmentations. Depending on the defect size, maxgraft® granules will be stably incorporated within 3–4 months and enable therefore an earlier re-entry in comparison to other grafting materials 2.

Looking for prices or further informations?

HIGH PATIENT ACCEPTANCE – SHORTER TREATMENT TIMES

Due to its high biological regenerative capacity and complete remodeling, maxgraft® represents an alternative to the patient’s own bone. The need for a second surgical site is eliminated, surgical time is shortened, and postoperative pain and morbidity for the patient are significantly reduced.

IMPLANTOLOGY, PERIODONTOLOGY, ORAL AND CMF SURGERY

  • Regeneration of extraction sockets (Socket Preservation)
  • Regeneration of missing bone tissue around dental implants
  • Sinus augmentation
  • Regeneration of periodontal bone defects
  • Three-dimensional (horizontal and/or vertical) ridge augmentation
  • Bony defects
Rehydration

The processing of maxgraft® products preserves the natural collagen content and a residual moisture of <10%. Thus, a rehydration is not mandatory. However, rehydration in blood or saline solution can facilitate the handling and the insertion of maxgraft® granules due to better sticking together.

Application

Compression of the particles should be avoided. Looser particles provide more space for blood vessel ingrowth and new bone formation.

Mixing with autologous bone

Mixing maxgraft® granules with autologous bone increases biological activity in the defect site and contributes to a more rapid regeneration and new bone formation.

Mixing with cerabone®

Mixing of maxgraft® granules with cerabone® combines the advantages of both materials. The biological potential of maxgraft® and the long-term volume stability of cerabone® lead to fast regeneration of strong vital bone.

Guided Bone Regeneration – Use of a barrier membrane

maxgraft® granules should be covered with a barrier membrane (e.g. Jason® membrane, collprotect® membrane) for the purpose of controlled bone regeneration; this prevents premature resorption and ingrowth of soft tissue.

Wound closure

Consideration of the soft tissue situation prior to surgery is necessary. The wound must be closed tension-free and saliva-proof. Overlapping mobilization of the soft tissue before suturing should be possible.

Reentry

Depending on the defect morphology, the healing time of maxgraft® granules is 3-4 months (e.g. socket preservation, smaller bone defects, periodontal defects). Following healing, reentry with implant placement should be performed promptly to prevent degradation.

  • Natural mineralized collagen
  • Three-dimensional pore network and rough surface
  • Osteoconductive scaffold which supports natural and controlled remodeling3,4

Product Specifications

maxgraft® cancellous granules

Art.-No. Particle Size Content
30005 < 2.0 mm 1 Ă— 0.5 ml
30010 < 2.0 mm 1 Ă— 1.0 ml
30020 < 2.0 mm 1 Ă— 2.0 ml
30040 < 2.0 mm 1 Ă— 4.0 ml
30005S 0.25–1mm 1 × 0.5 ml
30010S 0.25–1mm 1 × 1.0 ml
30020S 0.25–1mm 1 × 2.0 ml
30040S 0.25–1mm 1 × 4.0 ml
30005L 1.0–2.0 mm 1 × 0.5 ml
30010L 1.0–2.0 mm 1 × 1.0 ml
30020L 1.0–2.0 mm 1 × 2.0 ml
30040L 1.0–2.0 mm 1 × 4.0 ml

maxgraft® cortico-cancellous granules

Art.-No. Particle Size Content
31005 < 2.0 mm 1 Ă— 0.5 ml
31010 < 2.0 mm 1 Ă— 1.0 ml
31020 < 2.0 mm 1 Ă— 2.0 ml
31040 < 2.0 mm 1 Ă— 4.0 ml
31005S 0.25–1mm 1 × 0.5 ml
31010S 0.25–1mm 1 × 1.0 ml
31020S 0.25–1mm 1 × 2.0 ml
31040S 0.25–1mm 1 × 4.0 ml
31005L 1.0–2.0 mm 1 × 0.5 ml
31010L 1.0–2.0 mm 1 × 1.0 ml
31020L 1.0–2.0 mm 1 × 2.0 ml
31040L 1.0–2.0 mm 1 × 4.0 ml

Distribution

With our international network of distribution partners, we are near you in over 100 countries worldwide. In addition to our 360° productportfolio, we offer service, scientific advice and exchange, training and events directly on site from a single source.

Find a distribution partner near you:

SPECIFIC FACTS

maxgraft® granules are available in the form of both pure cancellous and cortico-cancellous granules. For the regeneration of bone defects, the cancellous structure enables rapid formation of new vital bone tissue, whereas the cortico-cancellous granules provide a higher volume stability. Greater volume stability is advantageous, for example, in augmentations outside the alveolar ridge contour. Depending on the defect size, maxgraft® granules are stably incorporated and partially remodeled within 3-4 months, thus enabling earlier re-entry compared to other bone graft substitutes 2.

maxgraft® is processed bone substitute material from human donors. All granules originate from femoral heads of living donors donated during hip arthroplasty surgery. Tissue procurement is standardized according to a predefined protocol and is performed by certified procurement centers. All tissue donations are made only after the donor has given written consent. In addition, the health status of the potential donor is assessed in advance as part of a risk analysis and the donor is then selected on the basis of strict exclusion criteria.

After a thorough analysis of the donors’ medical history, the high safety of maxgraft® is ensured by a series of stringent serological tests in combination with C+TBA’s  Allotec® purification process and final radiological sterilization.

C+TBA is certified as a tissue procurement facility and tissue bank according to §19 and §22 of the Austrian Tissue Safety Act.

Guide Bone substitute materials

Which product is most suitable for your indication, what are the alternatives and what do you have to pay particular attention to when using it? Our experts have compiled the most important information for you.

botissnews

Stay tuned

Stay informed and never miss any news: Product news, latest publications, exclusive events and exciting webinars. Simply fill out the registration form and you’re in.

Science

Education

Edutainment

Handling

Academy

0
Surgeries
0
Webinars
0
Specialists

RELATED PRODUCTS

  • maxgraft® cortico

    BONE AUGMENTATION WITH THE SHELL TECHNIQUE

    A prefabricated cortical bone strut from human donor bone.

  • maxgraft® blocks

    PROCESSED HUMAN ALLOGRAFT

    Allograft bone substitute from human donor bone, processed by the Cells+Tissuebank Austria with a special cleaning process

  • maxgraft® bonebuilder

    CUSTOMIZED ALLOGENIC BONE BLOCK

    A cancellous allogenic bone block made from human donor bone, individually adapted to the patient defect, which is prepared by Cells+Tissuebank Austria in a special purification process.

Contact

Send your questions about our products directly to our specialists:

Product Management

Any comments or questions?

Don’t hesitate to get in touch with us!

botiss biomaterials GmbH

Hauptstrasse 28
15806 Zossen / Germany
Tel.: +49 33769 / 88 41 985
Fax: +49 33769 / 88 41 986
  1. Solakoglu et al. Clin Implant Dent Relat Res. 2019, 21, 1002-1016.
  2. Wen et al. J. Periodont. 2019, 91(2):215 222.
  3. Trajkovski et al. Materials 2018, 11(2).
  4. Barbeck et al. Materials 2019, 12, 3234.